DE69613975D1 - Dialkyltiacumicine - Google Patents

Dialkyltiacumicine

Info

Publication number
DE69613975D1
DE69613975D1 DE69613975T DE69613975T DE69613975D1 DE 69613975 D1 DE69613975 D1 DE 69613975D1 DE 69613975 T DE69613975 T DE 69613975T DE 69613975 T DE69613975 T DE 69613975T DE 69613975 D1 DE69613975 D1 DE 69613975D1
Authority
DE
Germany
Prior art keywords
dialkyltiacumicine
compounds
colitis
administration
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69613975T
Other languages
English (en)
Other versions
DE69613975T2 (de
Inventor
B Mcalpine
E Hochlowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69613975D1 publication Critical patent/DE69613975D1/de
Publication of DE69613975T2 publication Critical patent/DE69613975T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
DE69613975T 1995-05-09 1996-05-02 Dialkyltiacumicine Expired - Fee Related DE69613975T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/437,761 US5583115A (en) 1995-05-09 1995-05-09 Dialkyltiacumicin compounds
PCT/US1996/006204 WO1996035702A1 (en) 1995-05-09 1996-05-02 Dialkyltiacumicin compounds

Publications (2)

Publication Number Publication Date
DE69613975D1 true DE69613975D1 (de) 2001-08-23
DE69613975T2 DE69613975T2 (de) 2002-04-04

Family

ID=23737769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69613975T Expired - Fee Related DE69613975T2 (de) 1995-05-09 1996-05-02 Dialkyltiacumicine

Country Status (12)

Country Link
US (1) US5583115A (de)
EP (1) EP0824539B1 (de)
JP (1) JPH11504937A (de)
AT (1) ATE203246T1 (de)
CA (1) CA2218916A1 (de)
DE (1) DE69613975T2 (de)
DK (1) DK0824539T3 (de)
ES (1) ES2159733T3 (de)
GR (1) GR3036873T3 (de)
MX (1) MX9708611A (de)
PT (1) PT824539E (de)
WO (1) WO1996035702A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
SI2070530T1 (sl) * 2004-05-14 2016-05-31 Merck Sharp & Dohme Corp. Zdravljenje bolezni, povezanih z uporabo antibiotikov
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
MX2007009196A (es) * 2005-01-31 2009-02-25 Optimer Pharmaceuticals Inc Compuestos macrocilicos de 18 miembros y analogos de los mismos.
CA2626698C (en) * 2005-10-21 2015-12-01 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
ZA200905337B (en) * 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
TWI523654B (zh) * 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
JP5825217B2 (ja) * 2012-07-27 2015-12-02 メルク シャープ アンド ドーム コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． １８員大環状化合物及びその類似化合物
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
UA122203C2 (uk) 2014-05-09 2020-10-12 Астеллас Фарма Юроп Лтд Схема лікування із застосуванням сполуки тіакуміцину
US10548912B2 (en) 2015-07-03 2020-02-04 Astellas Pharma Europe Ltd. Dosage regimen for a tiacumicin compound
EP3508492A1 (de) * 2018-01-08 2019-07-10 Universität Zürich Tiacumicinderivate und ihre verrwendung als antibiotika

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds

Also Published As

Publication number Publication date
US5583115A (en) 1996-12-10
DE69613975T2 (de) 2002-04-04
GR3036873T3 (en) 2002-01-31
EP0824539B1 (de) 2001-07-18
EP0824539A1 (de) 1998-02-25
ES2159733T3 (es) 2001-10-16
MX9708611A (es) 1998-02-28
CA2218916A1 (en) 1996-11-14
DK0824539T3 (da) 2001-09-24
JPH11504937A (ja) 1999-05-11
WO1996035702A1 (en) 1996-11-14
ATE203246T1 (de) 2001-08-15
PT824539E (pt) 2002-01-30

Similar Documents

Publication Publication Date Title
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
BG103947A (en) Derivatives of 9-oxymerythromycin
EA200100623A1 (ru) Кетолидные антибиотики
DE69613975D1 (de) Dialkyltiacumicine
TR200200435T2 (tr) Yeni makrolit antibiyotikler.
PT876388E (pt) Derivados de eritromicina triciclica
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
PT874863E (pt) Derivados 3-desoxi-3-descladinose de eritromicinasa e b

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee